Alpha 2.0
Login Register
» Authors » Lorenzo Orzalesi

Lorenzo Orzalesi

Explore the profile of Lorenzo Orzalesi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 1408
Followers 0
Related Specialties
Oncology
General Surgery
Biomedical Engineering
Top 10 Co-Authors
Lorenzo Livi
Icro Meattini
Simonetta Bianchi
Jacopo Nori
Marco Bernini
Calogero Saieva
Vieri Scotti
Donato Casella
Isacco Desideri
Giulio Francolini
Published In
Eur J Cancer
Breast Cancer
Clin Breast Cancer
Biomed Res Int
Radiother Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
B3 Breast Lesions: Positive Predictive Value and Follow-Up on a Large Single-Institution Series
Bernini M, Spolveri F, Tofani L, de Benedetto D, Bicchierai G, Bellini C, et al.
J Surg Res . 2024 May; 299:366-373. PMID: 38815523
Introduction: Lesions of uncertain malignant potential (B3) represent 10% of core needle biopsies (CNBs) or vacuum-assisted breast biopsies (VABBs). Traditionally, B3 lesions are operated on. This study investigated the association...
2.
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies
Bellini C, Pugliese F, Bicchierai G, Amato F, de Benedetto D, di Naro F, et al.
Breast Cancer . 2024 May; 31(5):851-857. PMID: 38811515
Background: To assess contrast-enhanced mammography (CEM) in the management of BI-RADS3 breast architectural distortions (AD) in digital breast tomosynthesis (DBT). Methods: We retrospectively reviewed 328 women with 332 ADs detected...
3.
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques
Salvestrini V, Valzano M, Meattini I, Becherini C, Visani L, Francolini G, et al.
Radiol Med . 2024 Apr; 129(6):845-854. PMID: 38602657
Introduction: Post-mastectomy radiotherapy (PMRT) improves local control rates and survival in patients with adverse prognostic features. The dose coverage to target volumes is critical to yield maximum benefit to treated...
4.
Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures
Bernini M, Gigliucci G, Cassetti D, Tommasi C, Gaggelli I, Arlia L, et al.
Gland Surg . 2024 Apr; 13(3):297-306. PMID: 38601291
Background: Reconstructive options that can be used following conservative mastectomy, skin-, nipple-sparing and skin-reducing mastectomies, allow a remarkable variety of safe methods to restore the natural shape and aesthetics of...
5.
Upgrade rate to malignancy of uncertain malignant potential breast lesions (B3 lesions) diagnosed on vacuum-assisted biopsy (VAB) in screen detected microcalcifications: Analysis of 366 cases from a single institution
Bianchi S, Caini S, Vezzosi V, Orzalesi L, Piovesan L, Mantellini P, et al.
Eur J Radiol . 2023 Dec; 170:111258. PMID: 38091661
Purpose: We retrospectively investigated clinical, radiological, and pathological features of B3 lesions associated with the risk of subsequent upgrade to malignancy. Methods: We included consecutive vacuum-assisted biopsies (VABs) performed during...
6.
Breast cancer: the first comparative evaluation of oncobiome composition between males and females
Niccolai E, Baldi S, Nannini G, Gensini F, Papi L, Vezzosi V, et al.
Biol Sex Differ . 2023 Jun; 14(1):37. PMID: 37277847
Background: Emerging evidence suggests that breast microbiota dysbiosis contributes to cancer initiation, progression, prognosis and treatment efficacy. Anyway, available data are referred only to female patients, and studies on males...
7.
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial
Bartels S, Donker M, Poncet C, Sauve N, Straver M, van de Velde C, et al.
J Clin Oncol . 2022 Nov; 41(12):2159-2165. PMID: 36383926
Purpose: The European Organisation for Research and Treatment of Cancer 10981-22023 AMAROS trial evaluated axillary lymph node dissection (ALND) versus axillary radiotherapy (ART) in patients with cT1-2, node-negative breast cancer...
8.
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer
Visani L, Livi L, Ratosa I, Orazem M, Ribnikar D, Saieva C, et al.
Radiother Oncol . 2022 Nov; 177:40-45. PMID: 36349599
Purpose: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) currently represent the standard of care for the initial treatment of patients with metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer....
9.
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
Meattini I, Francolini G, Di Cataldo V, Visani L, Becherini C, Scoccimarro E, et al.
Clin Transl Radiat Oncol . 2022 Sep; 37:94-100. PMID: 36177053
Background And Purpose: Preoperative partial breast irradiation (PBI) has got the advantage of treating a well-defined target. We report the results of the phase II ROCK trial (NCT03520894), enrolling early...
10.
Robot-assisted surgery in space: pros and cons. A review from the surgeon's point of view
Pantalone D, Faini G, Cialdai F, Sereni E, Bacci S, Bani D, et al.
NPJ Microgravity . 2021 Dec; 7(1):56. PMID: 34934056
The target of human flight in space has changed from permanence on the International Space Station to missions beyond low earth orbit and the Lunar Gateway for deep space exploration...